Literature DB >> 23212937

Raynaud's phenomenon of the nipple associated with labetalol use.

Naomi McGuinness1, Vicky Cording.   

Abstract

Raynaud's phenomenon of the nipple is an unusual cause of severe nipple pain. Precipitants for Raynaud's phenomenon of the nipple are known to be cold temperatures, caffeine, and emotional stress. Nipple pain is quoted as the most common cause of cessation of breastfeeding. It is important that lactation consultants and other health care professionals are aware of Raynaud's phenomenon of the nipple and the treatment options available. This is a case of a 37-year-old woman, Gravida 2, Para 1, who was first seen in the antenatal clinic at 34 weeks gestation. A diagnosis of Raynaud's phenomenon of the nipple was made after she began taking labetalol for pregnancy-induced hypertension. The phenomenon had occurred in both of her previous pregnancies on commencing labetalol and resolved postnatally on cessation of the drug. We aim to raise awareness of both the condition itself and the potential role of labetalol in the development of Raynaud's phenomenon of the nipple.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212937     DOI: 10.1177/0890334412467509

Source DB:  PubMed          Journal:  J Hum Lact        ISSN: 0890-3344            Impact factor:   2.219


  3 in total

1.  Nipple pain, damage, and vasospasm in the first 8 weeks postpartum.

Authors:  Miranda L Buck; Lisa H Amir; Meabh Cullinane; Susan M Donath
Journal:  Breastfeed Med       Date:  2013-12-31       Impact factor: 1.817

2.  Postpartum Nipple Symptoms: Risk Factors and Dermatologic Characterization.

Authors:  Leah Laageide; Stephanie Radke; Donna Santillan; Patrick Ten Eyck; Jennifer Powers
Journal:  Breastfeed Med       Date:  2020-12-18       Impact factor: 1.817

3.  Raynaud's phenomenon of the nipple as a side-effect of labetalol: Case report and literature review.

Authors:  Jesus Avila-Vega; Enrique Urrea-Mendoza; Christy Lee
Journal:  Case Rep Womens Health       Date:  2019-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.